|
Ms. VanLent is currently Executive Vice President and Chief Financial Officer for Barrier Therapeutics, Inc. an emerging specialty pharmaceutical company in the field of dermatology. Prior to joining Barrier in May 2002, Ms. VanLent was a founder of The Technology Compass Group, LLC, a healthcare/technology consulting firm. From mid-1997 through October 2001, Ms. VanLent was with Sarnoff Corporation, a privately-held research and development company which creates and commercializes electronic, biomedical, and information technologies, where her last position held was Executive Vice President, Portfolio Management, overseeing creation of spin-off companies and patent and licensing activities. Ms. VanLent served as President of AMV Associates, an emerging growth healthcare consulting firm from March 1994 through August 1997. She currently serves as a director of a private fuel cell development company and a director and member of the audit committee for Integra Life Science Holdings. Ms. VanLent received a B.A. in Physics from Mount Holyoke College. | 